C. Manlius

机构：Utah Cancer Specialists, Nagoya City University Hospital, New Mexico Cancer Center, Yonsei University Health System, UNM Comprehensive Cancer Center

发表论文 16 篇 · 总被引 560 次 · h-index 7

代表论文

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2 (2006 · Cellular and Molecular Life Sciences · 被引 213)
Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab (2010 · Journal of Clinical Oncology · 被引 209)
Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial. (2010 · Journal of Clinical Oncology · 被引 48)
Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab (2008 · Journal of Clinical Oncology · 被引 20)
RAD001 (everolimus) in combination with weekly paclitaxel and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to trastuzumab: a multicenter phase I clinical trial. (2009 · Cancer Research · 被引 15)
BOLERO-4: Phase 2 trial of first-line everolimus (EVE) plus letrozole (LET) in estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2-) advanced breast cancer (BC) (2016 · Annals of Oncology · 被引 13)